These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 11366112

  • 1. Salvage therapy: still more intuition than data.
    Gilden D.
    GMHC Treat Issues; 1999 Jan; 13(1):6-12. PubMed ID: 11366112
    [Abstract] [Full Text] [Related]

  • 2. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA.
    AIDS Clin Rev; 1999 Jan; ():139-91. PubMed ID: 10999220
    [No Abstract] [Full Text] [Related]

  • 3. Practical issues regarding the use of antiretroviral therapy for HIV infection.
    Deeks SG.
    West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):25-9. PubMed ID: 11367133
    [Abstract] [Full Text] [Related]

  • 9. Rescue me.
    Simmons P.
    Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J, Weber J, Machala L, Reinis M, Linka M, Brůcková M, Vandasová J, Stanková M, Konvalinka J.
    Acta Virol; 2005 Aug; 49(1):29-36. PubMed ID: 15929396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S, Ledergerber B, Böni J, Schüpbach J, Kronenberg A, Opravil M, Flepp M, Speck RF, Grube C, Rentsch K, Weber R, Günthard HF, Swiss HIV Cohort Study.
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Salvage therapy for HIV infection].
    Salzberger B.
    MMW Fortschr Med; 2005 Apr 25; 147 Spec No 1():32-7. PubMed ID: 16385870
    [Abstract] [Full Text] [Related]

  • 17. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P, Lazzarin A.
    Scand J Infect Dis Suppl; 2003 Apr 25; 106():66-70. PubMed ID: 15000588
    [Abstract] [Full Text] [Related]

  • 18. HIV resistance: the new enemy.
    Colvin R.
    Common Factor; 1997 Nov 25; (No 11):6-7. PubMed ID: 11364845
    [Abstract] [Full Text] [Related]

  • 19. Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients.
    Sabin CA, Wilkins E, Murphy M, Fisher M, de Ruiter A, Easterbrook PJ, Leen C, Vlahakis E, Cane PA, Li X, Pillay D, UK Expanded Access Amprenavir Programme.
    Antivir Ther; 2003 Aug 25; 8(4):301-8. PubMed ID: 14518699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.